In a major breakthrough for diabetes and weight management, the Central Drugs Standard Control Organisation (CDSCO) has approved Ozempic (semaglutide) for use in India. The once-a-week injectable drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback